Literature DB >> 22407460

Procollagen propeptides: serum markers for atrial fibrosis?

Hans-Ruprecht Neuberger1, Angela Cacciatore, Jan-Christian Reil, Stefan Gräber, Hans-Joachim Schäfers, Christian Ukena, Michael Böhm, Christian Mewis.   

Abstract

BACKGROUND: Atrial fibrosis and its spatial heterogeneity are regarded as a substrate for the perpetuation of atrial arrhythmias. During collagen synthesis and degradation, collagen propeptides and telopeptides are released into the blood. This study tested the hypothesis that serum markers of collagen turnover correlate with atrial fibrosis.
METHODS: We prospectively included 28 patients in sinus rhythm undergoing cardiac surgery. Plasma concentrations of the carboxy- and amino-terminal propeptide of procollagen type-I (PICP and PINP) and type-III (PIIINP), and the C-terminal telopeptide of type-I collagen (ICTP) were determined. Interstitial fibrosis of left (n = 10) and right atrial appendages (n = 28) was analyzed histologically.
RESULTS: We found a correlation between left and right atrial fibrosis (r (s) = 0.79, p < 0.01). Interestingly, the higher the interstitial collagen content, the higher was the spatial heterogeneity of fibrosis (r (s) = 0.90, p < 0.001). However, PICP, PIIINP, and ICTP were not correlated to left or right atrial collagen content, or to the spatial heterogeneity of atrial fibrosis. There was a weak and even negative correlation between the serum PINP concentration and the degree of fibrosis in both the left and the right atrium (r (s) = -0.65 (p = 0.04) and r (s) = -0.42 (p = 0.03), respectively).
CONCLUSIONS: A high degree of interstitial atrial fibrosis indicates a high degree of spatial heterogeneity of interstitial collagen. Although serum PICP is known to be correlated with ventricular fibrosis, this and other serum markers of collagen turnover (PINP, PIIINP, and ICTP) do not directly reflect atrial fibrosis in patients with severe cardiac disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407460     DOI: 10.1007/s00392-012-0440-6

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  15 in total

Review 1.  The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease.

Authors:  Begoña López; Arantxa González; Ramón Querejeta; Javier Díez
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

2.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

3.  Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation.

Authors:  J Risteli; I Elomaa; S Niemi; A Novamo; L Risteli
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

4.  Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat.

Authors:  Hans-Ruprecht Neuberger; Ulrich Schotten; Yuri Blaauw; Dirk Vollmann; Sabine Eijsbouts; Arne van Hunnik; Maurits Allessie
Journal:  J Am Coll Cardiol       Date:  2006-01-18       Impact factor: 24.094

5.  Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.

Authors:  R Querejeta; N Varo; B López; M Larman; E Artiñano; J C Etayo; J L Martínez Ubago; M Gutierrez-Stampa; J I Emparanza; M J Gil; I Monreal; J P Mindán; J Díez
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

6.  Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure.

Authors:  Michael Behnes; Ursula Hoffmann; Siegfried Lang; Christel Weiss; Parviz Ahmad-Nejad; Michael Neumaier; Martin Borggrefe; Martina Brueckmann
Journal:  Clin Res Cardiol       Date:  2010-11-11       Impact factor: 5.460

7.  Study of the factors related to atrial fibrillation after coronary artery bypass grafting: a search for a marker to predict the occurrence of atrial fibrillation before surgical intervention.

Authors:  Akira Sezai; Mitsumasa Hata; Tetsuya Niino; Yuji Kasamaki; Toshiko Nakai; Atsushi Hirayama; Kazutomo Minami
Journal:  J Thorac Cardiovasc Surg       Date:  2009-02-01       Impact factor: 5.209

8.  Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.

Authors:  Eleftherios M Kallergis; Emmanuel G Manios; Emmanuel M Kanoupakis; Hercules E Mavrakis; Dimitris A Arfanakis; Niki E Maliaraki; Chrisovalantis E Lathourakis; Gregory I Chlouverakis; Panos E Vardas
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

9.  Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis.

Authors:  G Klappacher; P Franzen; D Haab; M Mehrabi; M Binder; K Plesch; R Pacher; M Grimm; I Pribill; H G Eichler
Journal:  Am J Cardiol       Date:  1995-05-01       Impact factor: 2.778

10.  Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.

Authors:  Pekka Timonen; Jarkko Magga; Juha Risteli; Kari Punnonen; Esko Vanninen; Anu Turpeinen; Petri Tuomainen; Johanna Kuusisto; Olli Vuolteenaho; Keijo Peuhkurinen
Journal:  Int J Cardiol       Date:  2007-04-17       Impact factor: 4.164

View more
  8 in total

Review 1.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

Review 2.  Novel and nonpharmacologic approaches to cardio-protection in hypertension.

Authors:  Luca Donazzan; Felix Mahfoud; Dominik Linz; Sebastian Ewen; Christian Ukena; Michael Böhm
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

3.  Effectiveness of aldosterone antagonists for preventing atrial fibrillation after cardiac surgery in patients with systolic heart failure: a retrospective study.

Authors:  V Simopoulos; G Tagarakis; A Hatziefthimiou; I Skoularigis; F Triposkiadis; V Trantou; N Tsilimingas; I Aidonidis
Journal:  Clin Res Cardiol       Date:  2014-08-19       Impact factor: 5.460

Review 4.  Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation.

Authors:  Mohit K Turagam; Mahek Mirza; Paul H Werner; Jasbir Sra; David C Kress; A Jamil Tajik; Arshad Jahangir
Journal:  Cardiol Rev       Date:  2016 Mar-Apr       Impact factor: 2.644

5.  Connective tissue growth factor (CTGF/CCN2): diagnostic and prognostic value in acute heart failure.

Authors:  Michael Behnes; Martina Brueckmann; Siegfried Lang; Christel Weiß; Parviz Ahmad-Nejad; Michael Neumaier; Martin Borggrefe; Ursula Hoffmann
Journal:  Clin Res Cardiol       Date:  2013-10-22       Impact factor: 5.460

6.  High fibrosis indices in cerebrospinal fluid of patients with shunt-dependent post-traumatic chronic hydrocephalus.

Authors:  Xu Hao; Wang Junwen; Li Jiaqing; Li Ran; Zhang Zhuo; Huang Yimin; Jiao Wei; Sun Wei; Lei Ting
Journal:  Transl Neurosci       Date:  2016-09-09       Impact factor: 1.757

7.  Noninvasive biomarker-based risk stratification for development of new onset atrial fibrillation after coronary artery bypass surgery.

Authors:  Farhan Rizvi; Mahek Mirza; Susan Olet; Melissa Albrecht; Stacie Edwards; Larisa Emelyanova; David Kress; Gracious R Ross; Ekhson Holmuhamedov; A Jamil Tajik; Bijoy K Khandheria; Arshad Jahangir
Journal:  Int J Cardiol       Date:  2020-01-07       Impact factor: 4.164

Review 8.  Diagnostic and Prognostic Value of miRNAs after Coronary Artery Bypass Grafting: A Review.

Authors:  Ewelina Błażejowska; Tomasz Urbanowicz; Aleksandra Gąsecka; Anna Olasińska-Wiśniewska; Miłosz J Jaguszewski; Radosław Targoński; Łukasz Szarpak; Krzysztof J Filipiak; Bartłomiej Perek; Marek Jemielity
Journal:  Biology (Basel)       Date:  2021-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.